Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
N/A
EC/CAS
232-679-6
Name of the chemical
Starch
Concentration
N/A
General Information
Revision date
2022-03-15
Product name
RETROVIR CAPSULES
Product Synonyms
RETROVIR CAPSULES 100 MG * RETROVIR CAPSULES 250 MG * RETROVIR CAPSULAS *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
ViiV Healthcare Limited
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H341, H351, H373
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Germ cell mutagenicity Category 2 H341 - Suspected of causing genetic defects. Carcinogenicity Category 2 H351 - Suspected of causing cancer. Specific target organ toxicity - repeated Category 2 H373 - May cause damage to exposure organs through prolonged or repeated exposure.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
MICROCRYSTALLINE CELLULOSE, Starch, ZIDOVUDINE
Signal word
Warning
Hazard statements
H341 Suspected of causing genetic defects. H351 Suspected of causing cancer. H373 May cause damage to organs through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
50.88 % of the mixture consists of component(s) of unknown acute oral toxicity. 100 % of the mixture consists of component(s) of unknown acute dermal toxicity. 100 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 100 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 for additional information on health hazards.
